A 2026 review in the British Journal of Pharmacology identified weight-loss plateaus as one of the persistent challenges of GLP-1 therapy, noting that counter-regulatory systems, including the endocannabinoid system, actively resist further loss [3]
This allows your body to adjust to the medication, significantly reducing the risk of severe nausea
To help with that, MeAgain's GLP 1 app tracks symptoms like flatulence and cramps, offers simple tips for gentle relief and diet tweaks, and connects your notes to your medical team so you can get practical, supervised guidance
The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake
Oral absorption of semaglutide is considerably faster than subcutaneous administration
Approved to manage blood sugar levels in adults with type 2 diabetes